Haleos Labs Ltd (SMSL)

Currency in INR
1,131.30
+36.10(+3.30%)
Closed·
SMSL Scorecard
Full Analysis
Trading at a low earnings multiple
SMSL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,076.101,187.90
52 wk Range
959.801,749.65
Key Statistics
Bid/Ask
1,110.00 / 1,131.30
Prev. Close
1,131.3
Open
1,076.1
Day's Range
1,076.1-1,187.9
52 wk Range
959.8-1,749.65
Volume
1.8K
Average Volume (3m)
4.13K
1-Year Change
-19.4%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SMSL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Haleos Labs Ltd Company Profile

Haleos Labs Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers APIs in various therapeutic areas, such as anti ulcer, erectile dysfunction, anti gout, anesthesia, anti infective, anti obesity, antifungal, anti convulsant, anti emetic, ophthalmic, anti worm, and antiemetic. It is also developing APIs in the areas of anti depressant, anti psychotic, anti hypertension, veterinary, antiviral, and anticoagulant. In addition, the company offers intermediates in the anti ulcer, anti migraine, anti hypertension, erectile dysfunction, anti cancer, antifungal, anti obesity, anti emetic, anti depressant, anti worm, anti gout, anti infective, anti convulsant, antiviral, and anesthesia. It also exports its products. The company was formerly known as SMS Lifesciences India Limited and changed its name to Haleos Labs Limited in August 2025. Haleos Labs Limited was founded in 1990 and is based in Hyderabad, India.

Employees
574
Market
India

Compare SMSL to Peers and Sector

Metrics to compare
SMSL
Peers
Sector
Relationship
P/E Ratio
19.8x26.3x−0.5x
PEG Ratio
−6.180.230.00
Price/Book
1.7x3.2x2.6x
Price / LTM Sales
1.0x2.2x3.2x
Upside (Analyst Target)
-12.5%38.8%
Fair Value Upside
Unlock1.7%5.4%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 57.27%
Dividend Yield
0.13%
Industry Median 0.75%
Annualised payout
1.50
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 08, 2025
EPS / Forecast
13.75 / --
Revenue / Forecast
835.01M / --
EPS Revisions
Last 90 days

SMSL Income Statement

People Also Watch

277.85
ADTB
+0.14%
4,755.60
AVEU
+1.19%
3,276.60
TVSM
+0.63%
147.70
BSTS
+6.72%
1,805.50
SBIL
-0.62%

FAQ

What Stock Exchange Does Haleos Labs Trade On?

Haleos Labs is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Haleos Labs?

The stock symbol for Haleos Labs is "SMSL."

What Is the Haleos Labs Market Cap?

As of today, Haleos Labs market cap is 3.42B.

What Is Haleos Labs's Earnings Per Share (TTM)?

The Haleos Labs EPS (TTM) is 57.27.

From a Technical Analysis Perspective, Is SMSL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Haleos Labs Stock Split?

Haleos Labs has split 0 times.

How Many Employees Does Haleos Labs Have?

Haleos Labs has 574 employees.

What is the current trading status of Haleos Labs (SMSL)?

As of 31 Aug 2025, Haleos Labs (SMSL) is trading at a price of 1,131.30, with a previous close of 1,131.30. The stock has fluctuated within a day range of 1,076.10 to 1,187.90, while its 52-week range spans from 959.80 to 1,749.65.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.